Antisera against isolated capsid components of intermediate adenovirus strains, types 3-16 (the San Carlos agent) and 15-9 and of "parental" prototype strains were compared in neutralization tests, hemagglutination-inhibition (HI) tests employing soluble and virion-associated hemagglutinin as antigens, and by electron microscopy. Hexons of the intermediate strains were found to be similar to, but not identical to, those of the prototype strains with which a cross-reaction occurred in neutralization tests (types 3 and 15). In contrast, fibers of intermediate strains displayed characteristics relating them to the corresponding components of prototype strains to which a relationship has been found in HI tests. Fibers (and possibly even pentons) of types 9 and 15-9 appeared to be identical, whereas fibers of types 3-16 and 16 displayed antigen specificities of both common and unique nature. (17), for reasons given in a recent review (8a). To study the relationship of different structural components of the intermediate strains to the corresponding components of "parental" strains, immunological techniques were employed. Specific antisera against purified components of types 3, 3-16, and 16 (9), 15-9, and 15 (6) were prepared and then characterized by different serological tests and by electron microscopy. The results obtained demonstrated that intermediate strains carry hexons and fibers (or pentons) similar to or identical with those of the prototype strains, with which they cross-react in neutralization and HI tests.
type-specific antigens carried by hexons and fibers, respectively (3, 8a, 13) . The (1) and later studied by Wigand and co-workers (16, 18 ). An intermediate strain related to two prototypes of subgroup I has also been described. This strain was represented among the San Carlos agents isolated from cases of hepatitis occurring among children living in an Indian reservation in Arizona. It was found to behave similar to type 3 in neutralization tests and type 16 in HI tests (2) The aim of the present investigation was to explain the characteristics of intermediate strains by reference to immunological properties of different structural components occurring in their capsid.
For this purpose two different strains were studied. These are referred to as types 3-16 and 15-9. In this hyphenated expression the first and second figure denote the prototypes to which the intermediate strain is related in neutralization and HI tests, respectively. This descriptive formula deviates from that proposed by Wigand and Fliedner (17) , for reasons given in a recent review (8a) . To study the relationship of different structural components of the intermediate strains to the corresponding components of "parental" strains, immunological techniques were employed. Specific antisera against purified components of types 3, 3-16, and 16 (9), 15-9, and 15 (6) were prepared and then characterized by different serological tests and by electron microscopy. The results obtained demonstrated that intermediate strains carry hexons and fibers (or pentons) similar to or identical with those of the prototype strains, with which they cross-react in neutralization and HI tests.
MATERIAILS AND METHODS Virus and cell cultures. The prototype strains of types 3, 9 ("Hicks"), 15 (Ch 38), and 16 (CH 79) and the intermediate strains, type 3-16 (isolates SC-8 and SC-49; reference 2) and 15-9 (strain 5399, isolated by J. van der Veen, Nijmegen, Holland) were used. The latter two strains were kindly provided by G. J. Love, National Communicable Disease Center, Phoenix Field Station, Ariz., and R. Wigand, Homburg (Saar), Germany, respectively. Virus materials were prepared in a human embryonic lung cell line (Lu 106 cells) or a human bone-marrow cell line (MAS-A cells) by techniques previously described (4, 5) . Infected cultures were harvested at an advanced stage of virusinduced cell degeneration. The medium and cells were concentrated by forced dialysis against polyethylene glycol (Carbowax 6000, Union Carbide Corp., New York, N.Y.) and were frozen and thawed three times. NORRBY the concentrates were used for preparation of virus products.
Preparation of different virus products. Virons were prepared by centrifugation of stock materials in a discontinuous CsCl gradient by the technique described recently (12a). Soluble components remaining on top of the gradients were dialyzed against phosphatebuffered (0.067 M, pH 7.2) physiological saline and then separated further. The separation techniques employed were designed to give a distinct separation of fiber-associated structures (isolated fibers, fiber oligomers, pentons, penton oligomers, or dodecons) from hexons, to prepare specific antisera against these two capsid components. Absolute biochemical purification was not strived for. Techniques for separation of different type 3 components were already described (8) . Dodecons of types 9 and 15-9 were isolated by adsorption-elution on red cells (6, 11) , whereas dodecons and fibers of type 15 were prepared by zonal centrifugation and anion-exchange chromatography on diethylaminoethyl (DEAE)-Sephadex A 25 (Pharmacia Fine Chemicals, Uppsala, Sweden), respectively (6) . Monomers and oligomers (mostly dimers) of type 16 fibers, and pentons of type 3-16 were prepared by zonal centrifugation and exclusion chromatography on spherical agarose (BioGel A-15m; BioRad Laboratories, Richmond, Calif.), respectively (9) . None of these preparations contained demonstrable amounts of hexon complementfixing (CF) antigen. Hexons of all serotypes, except type 3-16, were isolated by anion-exchange chromatography on DEAE-Sephadex A25 (5, 6, 9) . Exclusion chromatography (Sephadex G200) was employed for preparation of hexons of type 3-16 (9) . All hexon preparations were devoid of any complete or incomplete hemagglutinin activity.
Preparation and absorption of hyperimmune sera. Rabbits were immunized with 4 ml of material mixed with Freund's complete adjuvant. After 5 weeks an intravenous booster injection of 1 to 2 ml was administered. At 1 week later, the animals were exsanguinated and serum was collected.
Absorption of sera was performed by mixing them with purified antigen in an amount calculated to be two to four times higher than that required to remove all antibody. After incubation at room temperature for 1 hr and at 4 C overnight, the samples were centrifuged at (Pi) a performance index of 16.2 (81,000 X g, rotor 40, Spinco Division, Beckman Instruments Inc., Calif.; reference 10) for 2 hr to remove antigen-antibody complexes.
Tests for biological activities. Serological techniques for demonstration of incomplete and complete hemagglutinins and CF antigen were already presented (5, 11) . The microtechnique of Takatsy (equipment supplied by Flow Laboratories, Irvine, Scotland) was employed. Antibody activities were measured in neutralization tests in tubes of diploid human lung cells, and in HI and in CF tests, by use of previously described techniques (8) .
Electron microscopy. The procedure for preparation of virion-antibody complexes was recently described (12) . All sera used were obtained by hyperimmunizations and, thus, contained mainly immunoglobulin G antibodies. All sera carried high titers of antibodies and, therefore, could be employed at dilutions of 1 to 100 or higher. This precluded the necessity for purification of virion-antibody complexes.
RESULTS
Neutralizing and HI antibody activities of sera against isolated soluble components (hexons and fiber-carrying structures) of different serotypes. In previous studies (8, 10) , it was found that antibodies against hexons of members of subgroups I (Fig. 1) . Correspondingly, antibodies against hexons of two types which behaved similarly in neutralization tests displayed a capacity to interact not only with their own virions but also those of the cross-reacting serotype (Fig. 1) . In some combinations, results of testing of various serum dilutions suggested that attachment of antibodies to the capsid of homotypic virions occurred more readily than attachment to virions of the crossreacting serotype. No such difference was seen in the case of type 9 and 15-9 antidodecon sera and type 3 and 15 antihexon sera. (9) and types 15 and 15-9 (6). Similar differences can be shown by use of the isoelectric focusing technique (Norrby, unpublished data) . Taken together, these data indicate that hexons of two serotypes crossreacting in neutralization tests are similar, but not identical, and that they both carry the antigen specificities which are responsible for interaction with neutralizing antibody. Since there appeared to be some differences in the capacity of sera to neutralize homotypic and heterotypic virions, it seems likely that the above-mentioned common antigen specificities are available to a varying extent at the surface of virions of different serotypes. This conclusion was also reached from studies on the structural basis for the crossneutralization observed between types 4 and 16 (10) .
Fibers of types 9 and 15-9 behaved identically in cross-absorption HI tests. Previous 
